Department of Neurosurgery, University of Michigan, R5018 BSRB 109 Zina Pitcher Place, Ann Arbor, MI, 48109, USA.
Pharm Res. 2023 Nov;40(11):2533-2540. doi: 10.1007/s11095-023-03550-9. Epub 2023 Jun 12.
This mini-review describes the role of the solute carrier (SLC)15 family of proton-coupled oligopeptide transporters (POTs) and particularly Pept2 (Slc15A2) and PhT1 (Slc15A4) in the brain. That family transports endogenous di- and tripeptides and peptidomimetics but also a number of drugs. The review focuses on the pioneering work of David E. Smith in the field in identifying the impact of PepT2 at the choroid plexus (the blood-CSF barrier) as well as PepT2 and PhT1 in brain parenchymal cells. It also discusses recent findings and future directions in relation to brain POTs including cellular and subcellular localization, regulatory pathways, transporter structure, species differences and disease states.
这篇迷你综述描述了溶质载体 (SLC)15 家族质子偶联寡肽转运体 (POTs),特别是 Pept2(Slc15A2)和 PhT1(Slc15A4)在大脑中的作用。该家族转运内源性二肽和三肽以及肽模拟物,但也转运许多药物。该综述重点介绍了 David E. Smith 在该领域的开创性工作,确定了 PepT2 在脉络丛(血脑屏障)以及 PepT2 和 PhT1 在脑实质细胞中的作用。它还讨论了与脑 POTs 相关的最新发现和未来方向,包括细胞和亚细胞定位、调节途径、转运体结构、物种差异和疾病状态。